Cargando…
Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia
The incidence of esophageal adenocarcinoma (EAC) is rising rapidly, and early detection within the precursor state of Barrett's esophagus (BE) is challenged by flat premalignant lesions that are difficult detect with conventional endoscopic surveillance. Overexpression of cell surface fibroblas...
Autores principales: | Zhou, Juan, He, Lei, Pang, Zhijun, Appelman, Henry D., Kuick, Rork, Beer, David G., Li, Meng, Wang, Thomas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675618/ https://www.ncbi.nlm.nih.gov/pubmed/29152066 http://dx.doi.org/10.18632/oncotarget.19764 |
Ejemplares similares
-
Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet
por: Wu, Xiaoli, et al.
Publicado: (2019) -
Detection of Barrett’s neoplasia with a near-infrared fluorescent heterodimeric peptide
por: Chen, Jing, et al.
Publicado: (2022) -
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas
por: Ferrer-Torres, Daysha, et al.
Publicado: (2016) -
Clinical characteristics of young patients with early Barrett’s neoplasia
por: Iwaya, Yugo, et al.
Publicado: (2019) -
Multiplexed endoscopic imaging of Barrett’s neoplasia using targeted fluorescent heptapeptides in a phase 1 proof-of-concept study
por: Chen, Jing, et al.
Publicado: (2021)